U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Adult-onset Still disease

MedGen UID:
39007
•Concept ID:
C0085253
•
Disease or Syndrome
Synonyms: Adult Still's disease; Still's disease adult onset
SNOMED CT: Adult onset Still disease (239920006); Adult onset Still's disease (239920006); Wissler-Fanconi syndrome (239920006)
Modes of inheritance:
Not genetically inherited
MedGen UID:
988794
•Concept ID:
CN307044
•
Finding
Source: Orphanet
clinical entity without genetic inheritance.
See: This record
Not genetically inherited (Orphanet)
 
Monarch Initiative: MONDO:0019355
Orphanet: ORPHA829

Definition

A rare inflammatory multisystem disorder characterized clinically by four cardinal signs: fever of unknown origin, arthralgia or arthritis, hyperleucocytosis, and typical skin rash. [from ORDO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAdult-onset Still disease

Professional guidelines

PubMed

Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.
Macovei LA, Burlui A, Bratoiu I, Rezus C, Cardoneanu A, Richter P, Szalontay A, Rezus E
Int J Mol Sci 2022 Oct 24;23(21) doi: 10.3390/ijms232112810. PMID: 36361602Free PMC Article
Current treatment options and safety considerations when treating adult-onset Still's disease.
Cavalli G, Farina N, Campochiaro C, Baldissera E, Dagna L
Expert Opin Drug Saf 2020 Dec;19(12):1549-1558. Epub 2020 Oct 27 doi: 10.1080/14740338.2020.1839411. PMID: 33078630
Tocilizumab for the treatment of adult-onset Still's disease.
Castañeda S, Martínez-Quintanilla D, Martín-Varillas JL, García-Castañeda N, Atienza-Mateo B, González-Gay MA
Expert Opin Biol Ther 2019 Apr;19(4):273-286. doi: 10.1080/14712598.2019.1590334. PMID: 30827128

Recent clinical studies

Etiology

Bibliometrics and Visual Analysis of Adult-onset Still Disease (1976-2020).
Xu B, Wang J, Meng X, Bao B
Front Public Health 2022;10:884780. Epub 2022 Jun 15 doi: 10.3389/fpubh.2022.884780. PMID: 35784223Free PMC Article
Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature review.
Gerfaud-Valentin M, Cottin V, Jamilloux Y, Hot A, Gaillard-Coadon A, Durieu I, Broussolle C, Iwaz J, Sève P
Medicine (Baltimore) 2016 Jul;95(30):e4258. doi: 10.1097/MD.0000000000004258. PMID: 27472698Free PMC Article
Updates in adult-onset Still disease: Atypical cutaneous manifestations and associations with delayed malignancy.
Sun NZ, Brezinski EA, Berliner J, Haemel A, Connolly MK, Gensler L, McCalmont TH, Shinkai K
J Am Acad Dermatol 2015 Aug;73(2):294-303. Epub 2015 Jun 6 doi: 10.1016/j.jaad.2015.04.063. PMID: 26054431
Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety.
Hong D, Yang Z, Han S, Liang X, Ma K, Zhang X
Drug Des Devel Ther 2014;8:2345-57. Epub 2014 Nov 25 doi: 10.2147/DDDT.S73428. PMID: 25473268Free PMC Article
Myocarditis in adult-onset still disease.
Gerfaud-Valentin M, Sève P, Iwaz J, Gagnard A, Broussolle C, Durieu I, Ninet J, Hot A
Medicine (Baltimore) 2014 Oct;93(17):280-289. doi: 10.1097/MD.0000000000000112. PMID: 25398063Free PMC Article

Diagnosis

Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis.
González García A, Fernández-Martín J, Robles Marhuenda Á
Rheumatology (Oxford) 2023 Apr 3;62(4):1426-1435. doi: 10.1093/rheumatology/keac481. PMID: 35997567Free PMC Article
Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.
Macovei LA, Burlui A, Bratoiu I, Rezus C, Cardoneanu A, Richter P, Szalontay A, Rezus E
Int J Mol Sci 2022 Oct 24;23(21) doi: 10.3390/ijms232112810. PMID: 36361602Free PMC Article
Tocilizumab for the treatment of adult-onset Still's disease.
Castañeda S, Martínez-Quintanilla D, Martín-Varillas JL, García-Castañeda N, Atienza-Mateo B, González-Gay MA
Expert Opin Biol Ther 2019 Apr;19(4):273-286. doi: 10.1080/14712598.2019.1590334. PMID: 30827128
Adult-onset Still disease.
Fautrel B
Best Pract Res Clin Rheumatol 2008 Oct;22(5):773-92. doi: 10.1016/j.berh.2008.08.006. PMID: 19028363
Rheumatoid arthritis: a review of the cutaneous manifestations.
Sayah A, English JC 3rd
J Am Acad Dermatol 2005 Aug;53(2):191-209; quiz 210-2. doi: 10.1016/j.jaad.2004.07.023. PMID: 16021111

Therapy

Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.
Macovei LA, Burlui A, Bratoiu I, Rezus C, Cardoneanu A, Richter P, Szalontay A, Rezus E
Int J Mol Sci 2022 Oct 24;23(21) doi: 10.3390/ijms232112810. PMID: 36361602Free PMC Article
Current treatment options and safety considerations when treating adult-onset Still's disease.
Cavalli G, Farina N, Campochiaro C, Baldissera E, Dagna L
Expert Opin Drug Saf 2020 Dec;19(12):1549-1558. Epub 2020 Oct 27 doi: 10.1080/14740338.2020.1839411. PMID: 33078630
Tocilizumab for the treatment of adult-onset Still's disease.
Castañeda S, Martínez-Quintanilla D, Martín-Varillas JL, García-Castañeda N, Atienza-Mateo B, González-Gay MA
Expert Opin Biol Ther 2019 Apr;19(4):273-286. doi: 10.1080/14712598.2019.1590334. PMID: 30827128
Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety.
Hong D, Yang Z, Han S, Liang X, Ma K, Zhang X
Drug Des Devel Ther 2014;8:2345-57. Epub 2014 Nov 25 doi: 10.2147/DDDT.S73428. PMID: 25473268Free PMC Article
Adult-onset Still disease.
Fautrel B
Best Pract Res Clin Rheumatol 2008 Oct;22(5):773-92. doi: 10.1016/j.berh.2008.08.006. PMID: 19028363

Prognosis

Adult-Onset Still's Disease-A Complex Disease, a Challenging Treatment.
Macovei LA, Burlui A, Bratoiu I, Rezus C, Cardoneanu A, Richter P, Szalontay A, Rezus E
Int J Mol Sci 2022 Oct 24;23(21) doi: 10.3390/ijms232112810. PMID: 36361602Free PMC Article
Tocilizumab for the treatment of adult-onset Still's disease.
Castañeda S, Martínez-Quintanilla D, Martín-Varillas JL, García-Castañeda N, Atienza-Mateo B, González-Gay MA
Expert Opin Biol Ther 2019 Apr;19(4):273-286. doi: 10.1080/14712598.2019.1590334. PMID: 30827128
Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature review.
Gerfaud-Valentin M, Cottin V, Jamilloux Y, Hot A, Gaillard-Coadon A, Durieu I, Broussolle C, Iwaz J, Sève P
Medicine (Baltimore) 2016 Jul;95(30):e4258. doi: 10.1097/MD.0000000000004258. PMID: 27472698Free PMC Article
Updates in adult-onset Still disease: Atypical cutaneous manifestations and associations with delayed malignancy.
Sun NZ, Brezinski EA, Berliner J, Haemel A, Connolly MK, Gensler L, McCalmont TH, Shinkai K
J Am Acad Dermatol 2015 Aug;73(2):294-303. Epub 2015 Jun 6 doi: 10.1016/j.jaad.2015.04.063. PMID: 26054431
Adult-onset Still disease.
Fautrel B
Best Pract Res Clin Rheumatol 2008 Oct;22(5):773-92. doi: 10.1016/j.berh.2008.08.006. PMID: 19028363

Clinical prediction guides

Heliotrope-like manifestation of adult-onset Still disease with macrophage activation syndrome: A case-based review.
Ikeda T, Yokoyama K, Kawakami T
J Dermatol 2022 Jul;49(7):736-740. Epub 2022 Apr 19 doi: 10.1111/1346-8138.16373. PMID: 35438204
Efficacy of tight control strategy in the treatment of adult-onset Still disease.
Malek Mahdavi A, Khalili A, Alihosseini S, Jaberinezhad M, Esalatmanesh K, Hajialilo M, Seyedmardani S, Khabbazi A
Clin Rheumatol 2021 Oct;40(10):3941-3949. Epub 2021 May 10 doi: 10.1007/s10067-021-05758-9. PMID: 33970381
Current treatment options and safety considerations when treating adult-onset Still's disease.
Cavalli G, Farina N, Campochiaro C, Baldissera E, Dagna L
Expert Opin Drug Saf 2020 Dec;19(12):1549-1558. Epub 2020 Oct 27 doi: 10.1080/14740338.2020.1839411. PMID: 33078630
Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety.
Hong D, Yang Z, Han S, Liang X, Ma K, Zhang X
Drug Des Devel Ther 2014;8:2345-57. Epub 2014 Nov 25 doi: 10.2147/DDDT.S73428. PMID: 25473268Free PMC Article
Adult-onset Still disease.
Fautrel B
Best Pract Res Clin Rheumatol 2008 Oct;22(5):773-92. doi: 10.1016/j.berh.2008.08.006. PMID: 19028363

Recent systematic reviews

The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.
Novelli L, Motta F, De Santis M, Ansari AA, Gershwin ME, Selmi C
J Autoimmun 2021 Feb;117:102592. Epub 2020 Dec 14 doi: 10.1016/j.jaut.2020.102592. PMID: 33401171Free PMC Article
A systematic review of the off-label use of biological therapies in systemic autoimmune diseases.
Ramos-Casals M, Brito-Zerón P, Muñoz S, Soto MJ; BIOGEAS STUDY Group
Medicine (Baltimore) 2008 Nov;87(6):345-364. doi: 10.1097/MD.0b013e318190f170. PMID: 19011506

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Reviews

    Related information

    • MeSH
      Related Medical Subject Headings
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...